Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (9): 862-866.DOI: 10.3969/j.issn.1673-8640.2025.09.006
Previous Articles Next Articles
FU Ai
Received:
2024-04-27
Revised:
2025-02-19
Online:
2025-09-30
Published:
2025-09-30
CLC Number:
FU Ai. Relationship between serum miR-125b and miR-423 expressions in patients with pulmonary tuberculosis and the disease activity and prognosis[J]. Laboratory Medicine, 2025, 40(9): 862-866.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.09.006
基因名称 | 上游引物(5'~3') | 下游引物(5'~3') |
---|---|---|
miR-125b | TCCCTGAGACCCTAACTTGTGA | AGTCTCAGGGTCC GAGGTATTC |
miR-423 | CGAAGTTCCCTTTGTCATCCT | GTGCAGGGTCCGAGGTATTC |
U6 | CTCGCTTCGGCAGCACA | AACGCTTCACGAATTTGCGT |
基因名称 | 上游引物(5'~3') | 下游引物(5'~3') |
---|---|---|
miR-125b | TCCCTGAGACCCTAACTTGTGA | AGTCTCAGGGTCC GAGGTATTC |
miR-423 | CGAAGTTCCCTTTGTCATCCT | GTGCAGGGTCCGAGGTATTC |
U6 | CTCGCTTCGGCAGCACA | AACGCTTCACGAATTTGCGT |
组别 | 例数 | miR-423 | miR-125b | TNF-α/(pg·mL-1) | IL-6/(pg·mL-1) |
---|---|---|---|---|---|
APTB组 | 102 | 2.37±0.64*# | 2.50±0.66*# | 23.97±6.13*# | 75.08±19.36*# |
LTBI组 | 112 | 1.79±0.46* | 1.87±0.48* | 10.82±2.72* | 39.67±9.95* |
正常对照组 | 120 | 0.97±0.25 | 1.01±0.26 | 2.82±0.72 | 5.17±1.33 |
F值 | 252.710 | 265.894 | 880.279 | 910.533 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | miR-423 | miR-125b | TNF-α/(pg·mL-1) | IL-6/(pg·mL-1) |
---|---|---|---|---|---|
APTB组 | 102 | 2.37±0.64*# | 2.50±0.66*# | 23.97±6.13*# | 75.08±19.36*# |
LTBI组 | 112 | 1.79±0.46* | 1.87±0.48* | 10.82±2.72* | 39.67±9.95* |
正常对照组 | 120 | 0.97±0.25 | 1.01±0.26 | 2.82±0.72 | 5.17±1.33 |
F值 | 252.710 | 265.894 | 880.279 | 910.533 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | miR-423 | miR-125b | TNF-α/(pg·mL-1) | IL-6/(pg·mL-1) |
---|---|---|---|---|---|
临床控制组 | 86 | 2.12±0.55 | 2.25±0.57 | 17.52±4.48 | 70.83±18.16 |
未控制组 | 16 | 3.69±1.11 | 3.82±1.13 | 58.62±15.01 | 97.90±25.81 |
t值 | 8.674 | 8.432 | 21.168 | 5.099 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | miR-423 | miR-125b | TNF-α/(pg·mL-1) | IL-6/(pg·mL-1) |
---|---|---|---|---|---|
临床控制组 | 86 | 2.12±0.55 | 2.25±0.57 | 17.52±4.48 | 70.83±18.16 |
未控制组 | 16 | 3.69±1.11 | 3.82±1.13 | 58.62±15.01 | 97.90±25.81 |
t值 | 8.674 | 8.432 | 21.168 | 5.099 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
项目 | AUC(95%CI①) | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|
miR-423 | 0.830(0.743~0.897) | 3.47 | 68.75 | 84.88 | 0.536 |
miR-125b | 0.852(0.769~0.915) | 3.00 | 75.00 | 77.91 | 0.529 |
miR-423+miR-125b | 0.910(0.837~0.958) | 0.147 | 81.25 | 90.70 | 0.720 |
miR-423+miR-125b+TNF-α+IL-6 | 0.942(0.866~0.989) | 0.284 | 88.37 | 94.11 | 0.785 |
项目 | AUC(95%CI①) | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|
miR-423 | 0.830(0.743~0.897) | 3.47 | 68.75 | 84.88 | 0.536 |
miR-125b | 0.852(0.769~0.915) | 3.00 | 75.00 | 77.91 | 0.529 |
miR-423+miR-125b | 0.910(0.837~0.958) | 0.147 | 81.25 | 90.70 | 0.720 |
miR-423+miR-125b+TNF-α+IL-6 | 0.942(0.866~0.989) | 0.284 | 88.37 | 94.11 | 0.785 |
[1] | FUKUNAGA R, GLAZIOU P, HARRIS J B, et al. Epidemiology of tuberculosis and progress toward meeting global targets-worldwide,2019[J]. MMWR Morb Mortal Wkly Rep, 2021, 70(12):427-430. |
[2] | SUDBURY E L, CLIFFORD V, MESSINA N L, et al. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI:a systematic review[J]. J Infect, 2020, 81(6):873-881. |
[3] |
SEIFERT M, VARGAS E, RUIZ-VALDEPEÑAS MONTIEL V, et al. Detection and quantification of Mycobacterium tuberculosis antigen CFP10 in serum and urine for the rapid diagnosis of active tuberculosis disease[J]. Sci Rep, 2021, 11(1):19193.
DOI PMID |
[4] | CHAI Q, ZHANG Y, LIU C H. Mycobacterium tuberculosis:an adaptable pathogen associated with multiple human diseases[J]. Front Cell Infect Microbiol, 2018, 8:158. |
[5] |
杨丽媛, 戴碗琴, 汪小桐, 等. 外周血中性粒细胞对γ干扰素释放试验结果的影响[J]. 检验医学, 2023, 38(5):484-488.
DOI |
[6] | SINIGAGLIA A, PETA E, RICCETTI S, et al. Tuberculosis-associated microRNAs:from pathogenesis to disease biomarkers[J]. Cells, 2020, 9(10):2160. |
[7] | TU H, YANG S, JIANG T, et al. Elevated pulmonary tuberculosis biomarker miR-423-5p plays critical role in the occurrence of active TB by inhibiting autophagosome-lysosome fusion[J]. Emerg Microbes Infect, 2019, 8(1):448-460. |
[8] | LIU G, WAN Q, LI J, et al. Silencing miR-125b-5p attenuates inflammatory response and apoptosis inhibition in mycobacterium tuberculosis-infected human macrophages by targeting DNA damage-regulated autophagy modulator 2(DRAM2)[J]. Cell Cycle, 2020, 19(22):3182-3194. |
[9] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断 [S].北京: 中华人民共和国国家卫生和计划生育委员会, 2018. |
[10] | 中华医学会. 临床诊疗指南:结核病分册[M]. 北京: 人民卫生出版社, 2005. |
[11] | 季辉, 田爱平, 卢丽艳, 等. 2010—2020年沧州地区肺结核的流行病学特征及危险因素分析[J]. 公共卫生与预防医学, 2021, 32(5):105-108. |
[12] | HUANG L, NAZAROVA E V, RUSSELL D G. Mycobacterium tuberculosis:bacterial fitness within the host macrophage[J]. Microbiol Spectr, 2019, 7(2):10. |
[13] | SHI L, JIANG Q, BUSHKIN Y, et al. Biphasic dynamics of macrophage immunometabolism during Mycobacterium tuberculosis infection[J]. mBio, 2019, 10(2):e02550. |
[14] | KALAYCI YÜKSEK F, KIĞ C, ORTAKÖYLÜ G, et al. Association between active pulmonary tuberculosis and circulating microRNAs:a preliminary study from Turkey[J]. Turk J Med Sci, 2021, 51(4):1894-1904. |
[15] | 李观强, 张娟娟, 梁娟, 等. miR-20a-5p在肺结核外周血单核细胞中的表达及临床价值[J]. 中国免疫学杂志, 2019, 35(14):1739-1742. |
[16] | TRIBOLET L, KERR E, COWLED C, et al. MicroRNA biomarkers for infectious diseases:from basic research to biosensing[J]. Front Microbiol, 2020, 11:1197. |
[17] | 王静娴, 刘雪琴, 仝桃玲, 等. 结核性脑膜炎患儿外周血miR-125b及脑脊液β2微球蛋白表达及临床意义[J]. 中华医院感染学杂志, 2021, 31(9):1431-1435. |
[18] | AHMAD F, RANI A, ALAM A, et al. Macrophage:a cell with many faces and functions in tuberculosis[J]. Front Immunol, 2022, 13:747799. |
[19] | 耿晓平, 王鲜茹, 丁雅芳, 等. 活动性肺结核外周血miR-28-3p与miR-93-5p及miR-574-5p表达及临床意义[J]. 中华医院感染学杂志, 2021, 31(11):1617-1622. |
[20] | 杨盛娅, 永艳, 崔岩飞, 等. 肺结核患者医院感染后外周血miR-29a-3p水平与巨噬细胞因子的相关性研究[J]. 中华医院感染学杂志, 2018, 28(15):2253-2256. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||